USPTO serial 86922898
SOLVERIS
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRIEDMAN, LESLEE ANN
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SOLVERIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Austin Padgett
AUSTIN PADGETT TROUTMAN SANDERS LLP600 PEACHTREE ST. NE, SUITE 5200ATLANTA, GA 30308UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | polymers for making pharmaceutical compositions | ACTIVE | — |
| 005 | Pharmaceutical preparations and medications for use in the treatment of hypotension in the setting of anesthesia; Medical devices for use in the treatment of respiratory diseases and disorders; Pharmaceutical preparations and medications for treating pain management, respiratory diseases and disorders, allergic disorders, gastrointestinal disorders, sleep disorders, dermatological conditions, pulmonary diseases, obstetrics and gynecology; Pharmaceutical products, namely pharmaceutical agents and preparations for the treatment of autoimmune diseases, bacterial infections, chronic anemia, hypotension, disorders of the musculo-skeletal system, for maintaining blood pressure, for the reversal of the effects of anesthesia, for the reversal of the effects of non-depolarizing neuromuscular blocking agents; chemical preparations for medical and veterinary purposes for injection or oral administration, namely, a drug delivery system in the form of coatings, tablets that provide continuous and controlled release of active ingredients in a wide variety of therapeutic agents to human patients; drug delivery agents in the form of encapsulated pharmaceutical preparations for the prolonged and controlled release of active ingredients, for the treatment of a wide variety of diseases and disorders; injectable medication used to reverse anesthesia; medication used to maintain blood pressure | ACTIVE | — |
| 042 | provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis | ACTIVE | — |
| 044 | Provision of pharmaceutical information and advice | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2016 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Aug 19, 2016 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Aug 16, 2016 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jul 28, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2016 | NWAP | NEW APPLICATION ENTERED | — |